Exercise may shield hearts from chemo damage, new study hopes
NCT ID NCT04467411
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a physical exercise program can prevent heart damage in breast cancer patients receiving a type of chemotherapy called anthracycline. About 70 participants will be randomly assigned to exercise or usual care. Researchers will use heart scans and blood tests to see if exercise helps keep the heart healthy and to detect early warning signs of trouble.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
physical exercise intervention
What this could lead to
If successful, this could point toward a simple, drug-free way to protect the heart during breast cancer chemotherapy.
What could go wrong
This is a small, early-stage study (70 participants) focused on detecting early heart changes, not yet proving that exercise prevents heart failure. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cardiac Research Office, Aberdeen Royal Infirmary
Aberdeen, Aberdeenshire, AB25 2ZD, United Kingdom
-
Cardiovascular Research Facility
Aberdeen, Aberdeenshire, AB25 2ZD, United Kingdom